QALY Weights for Diabetic Retinopathy-A Comparison of Health State Valuations with HUI-3, EQ-5D, EQ-VAS, and TTO

In cost-utility analyses, the choice of quality-adjusted life-year measure may affect whether an intervention is considered cost-effective. Furthermore, if decisions are to be based on values from the general public, HUI-3 can be recommended for cost-utility analyses of interventions directed at diabetic retinopathy.